Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
8
×
boston top stories
national blog main
life sciences
biotech
national top stories
boston
new york blog main
new york top stories
san francisco blog main
san francisco top stories
clinical trials
fda
san diego blog main
san diego top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
ipo
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
astrazeneca
cancer
cancer drugs
covid-19
depression
diagnostics
drugs
What
way
8
×
ipo
new
biotechs
cancer
company
debut
drug
ipos
make
medical
medicine
medicines
moves
public
research
tech
week
acquisitions
alnylam
approves
biggest
bio
biotech
boston
build
buy
cancer’s
cash
cells
centers
central
ceo
chose
close
cns
coming
company’s
covers
cut
Language
unset
Current search:
way
×
" boston blog main "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Boston Tech Watch: Polaris, GE, DataRobot, Facial Recognition Woes
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
6 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?